Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Diagnosis of Acute Gouty Arthritis Obscured by Anchoring Bias

Sneha Patel, MD, Monica Mohile, MD, & Arundathi Jayatilleke, MD  |  Issue: April 2017  |  April 19, 2017

In addition, patients need to adhere to a dietary regimen and a healthy lifestyle to help prevent further attacks.

Our patient was maintained on colchicine 0.6 mg three times a day and discharged on febuxostat, after which outpatient uric acid levels decreased to normal levels for the first time in four years.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The earliest changes that can be seen in a patient with septic joints include soft tissue swelling & joint space widening or narrowing. Evidence of superimposed osteomyelitis can be seen in the form of periosteal bone reaction & bone destruction.1

Question 3

What is (are) the most common outcome(s) of untreated gout? (Multiple choices may be correct.)

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

a. sepsis
b. urolithiasis
c. permanent joint destruction
d. bacteremia
e. tophi

Gout is an inflammatory disorder in which uric acid, a toxic metabolic product, accumulates in the form of crystals in the joint spaces. Unabated accumulation of urate can result in tophi that present as papules or nodules in various locations, including tendons, cartilage, osteoarthritis nodes and bursae. The presence of tophi increases the risk of developing joint deformities and secondary osteoarthritis. Following injury, these tophi can become acutely inflamed and even erupt through the skin.

Approximately 20% of patients with chronic gout will develop nephrolithiasis due to both uric acid formation and calcium oxalate deposition.2 This may lead to obstructive nephropathy and subsequent infection.

Figures 1 & 2: X-rays of the Right Knee

Figures 1 & 2: X-rays of the Right Knee

Question 4

Which of the following can be used to aid in the diagnosis of gout? (Multiple answer choices may be correct.)

a. synovial fluid analysis
b. demonstration of fever and joint pains
c. clinical evidence of gout
d. imaging evidence of urate deposition
e. all of the above

In 2015, the ACR released new criteria for the classification of gout.3 These criteria emphasize physical exam and medical history, with less focus on laboratory results or invasive diagnostic techniques, such as synovial fluid analysis; the sensitivity of joint aspiration can be low, based on the size of the joint space, as well as the experience of the person obtaining and/or examining the sample.

These criteria utilize a point system in which different symptoms and signs are taken into account: distribution of joint involvement, presence of pain and/or erythema, time course of symptomatic episode, clinical evidence of tophi, serum urate levels, synovial fluid analysis, imaging evidence of urate deposition and/or joint damage. Negative points are given for serum urate levels <4 mg/dL and negative synovial findings. A Web-based calculator can be accessed through the ACR’s website.

Question 5

Is it typical to have gout in a patient with known seropositive RA?

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:anchoring biasArthritiscase reportClinicalDiagnosisdiagnostic testingGoutinflammationjointoutcomepatient carepolyarthralgiaRArheumatologistrheumatologyseropositive rheumatoid arthritisTreatment

Related Articles

    Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

    October 14, 2019

    Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

    Difficult Gout

    July 1, 2007

    “Grandpapa’s Torments” was the Rodnan Commemorative Gout Print featured at the 2005 ACR/ARHP Annual Scientific Meeting.

    Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’

    November 10, 2021

    Dr. Lisa Stamp helps filter the noise to get to the key insights from the research abstracts on gout presented at ACR Convergence 2021.

    Lost and found

    Understanding the Role of Uric Acid in Gout

    September 6, 2022

    From the first substantial argument in the 19th century that uric acid played a role in gout, it took about 100 years for the medical community to accept its role in triggering acute inflammatory gout attacks. Two papers, both published in 1962, helped demonstrate the link between uric acid and acute gout attacks, quickly opening…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences